Broward Health Offers Doses to High-Risk Patients – NBC 6 South Florida



[ad_1]

As a limited supply of the coronavirus vaccine has become available across Florida, residents are understandably eager to know when they can line up for a dose.

One of South Florida’s largest hospitals will open its doors to vaccine-seeking patients who are much younger than state requirements – provided they meet certain requirements.

Here’s what we know today about the coronavirus outbreak in Florida and the efforts to stop it.

Slots remain open at CVS locations in South Florida

Days after news was announced that sites in South Florida – in Miami-Dade and Broward – would offer the vaccine, slots remain open at CVS sites in the region.

To register for an appointment, click on this link to see the locations with openings.


Elderly People Get Vaccinated At Chen Medical Centers

Up to 1,100 pre-programmed COVID-19 vaccines will be administered safely on Saturday at the two new centers in Miami-Dade and Broward counties.

The events, held at 2230 Northwest 95th Street in Miami and 3460 North Andrews Avenue in Oakland Park, are part of a strategic and multifaceted alliance with the Florida Department of Health to better protect thousands of seniors in underserved neighborhoods of the coronavirus pandemic.


Broward Health to Offer Vaccines to High-Risk People 18 Years and Older

Broward Health announced Friday that it has opened appointments for the COVID-19 vaccine for those at risk aged 18 and older.

As of Friday afternoon, all appointments were filled, according to a spokesperson for Broward Health. It’s unclear exactly when the healthcare system will open another round of appointments, but it will likely be next week.

Patients 18 years and older who meet one of the high-risk groups are only eligible for the vaccine by appointment.


FDA panel unanimously recommends Johnson & Johnson vaccine

A key Food and Drug Administration advisory committee on Friday supported Johnson & Johnson’s single-injection coronavirus vaccine for emergency use.

The recommendation is a critical step in paving the way for a third preventive treatment to be distributed in the United States next week.

The non-binding decision, which was passed 22-0, by the FDA’s Advisory Committee on Vaccines and Related Biologics, comes as the Biden administration strives to increase the supply of vaccine doses and get Americans vaccinated as quickly as possible.



[ad_2]

Source link